(Q31944726)

English

Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1: implications for antibody-mediated PAI-1-neutralization and vitronectin-binding

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Epitope mapping for four monoclonal antibodies against human plasminogen activator inhibitor type-1: implications for antibody-mediated PAI-1-neutralization and vitronectin-binding (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

T Wind

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

M A Jensen

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

P A Andreasen

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

268

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1095-1106

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Role of vitronectin and its receptors in haemostasis and vascular remodeling

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

The urokinase-type plasminogen activator system in cancer metastasis: a review

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

The plasminogen activation system in tumor growth, invasion, and metastasis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

An ester bond linking a fragment of a serine proteinase to its serpin inhibitor.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Structure of a serpin-protease complex shows inhibition by deformation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

The role of conformational change in serpin structure and function

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Structural basis of latency in plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Serpin tertiary structure transformation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Libraries of peptides and proteins displayed on filamentous phage

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Glycerol diversifies phage repertoire selections and lowers non-specific phage absorption

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Tools for the production and purification of full-length, N- or C-terminal 32P-labeled protein, applied to HIV-1 Gag and Rev.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Comparing the predicted and observed properties of proteins encoded in the genome of Escherichia coli K-12.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Filamentous phage display of oligopeptide libraries.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

The crystal structure of plasminogen activator inhibitor 2 at 2.0 A resolution: implications for serpin function

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Crystal structure of ovalbumin as a model for the reactive centre of serpins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Functional effects of single amino acid substitutions in the region of Phe113 to Asp138 in the plasminogen activator inhibitor 1 molecule

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

The urokinase receptor is a major vitronectin-binding protein on endothelial cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

The role of plasminogen activator inhibitor-1 as inhibitor of platelet and megakaryoblastic cell adhesion

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

The structure of a serpin-protease complex revealed by intramolecular distance measurements using donor-donor energy migration and mapping of interaction sites

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Serpin-protease complexes are trapped as stable acyl-enzyme intermediates

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Neutralization of plasminogen activator inhibitor-1 inhibitory properties: identification of two different mechanisms

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Determination of the vitronectin binding site on plasminogen activator inhibitor 1 (PAI‐1)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Epitopes on plasminogen activator inhibitor type-1 important for binding to tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

High resolution functional analysis of antibody-antigen interactions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Protein movement during complex-formation between tissue plasminogen activator and plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Importance of the hinge region between alpha-helix F and the main part of serpins, based upon identification of the epitope of plasminogen activator inhibitor type 1 neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.2680041095.X

21 January 2018

Identifiers

10.1046/J.1432-1327.2001.2680041095.X

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31944726&oldid=1985142127"